Post-Authorisation Safety Cohort Observation of Retacrit™ (epoetin zeta) Administered Subcutaneously for the Treatment of Renal Anaemia (PASCO II) (PASCOII)

First published 09/07/2013

Last updated 22/02/2024

EU PAS number:

EUPAS4276

Study

Finalised

Documents

Study protocol

Initial protocol

PASCO II Protocol Version 4.0_20 March 2015_Signed

English (550.3 KB - PDF)View document

Updated protocol

C1111006 Protocol Amendment 4 (clean) 02 August 2019

First published: 22/02/2024

English (1.75 MB - PDF)View document

Study results

epoe-09-11-abstract

English (1.89 MB - PDF)View document

Study report

epoe-09-11-report-body

English (8.5 MB - PDF)View document

Other information

ENCePP Seal

ENCePP Seal documents

Secondary tabs